Article information
Full text is only aviable in PDF
Bibliografía
[1.]
S.C. Siegel.
History of asthma deaths from antiquity.
J Allergy Clin Immunol, 80 (1987), pp. 458-462
[2.]
R. Jackson, M.R. Sears, R. Beaglehole, H.H. Rea.
International trends in asthma mortality: 1970 to 1985.
Chest, 94 (1988), pp. 914-919
[3.]
J. Crane, C. Burgess, R. Beasley, N. Pearce.
Withdrawal of fenoterol and the end of the asthma mortality epidemic in New Zealand.
Thorax, 48 (1993), pp. 1.056
[4.]
M.R. Sears, H.H. Rea, R.P.G. Rothwell, T.V. O’Donnell, P.E. Holst, A.J.D. GiUies, et al.
Asthma mortality: comparison between New Zealand and England.
Br Med J, 293 (1986), pp. 1.342-1.345
[5.]
J.M. Kallenbach, A.H. Frankel, S.E. Lapinsky, A.S. Thomton, J.A. Blott, C. Smith, et al.
Determinants of near fatality in acute severe asthma.
Am J Med, 95 (1993), pp. 265-272
[6.]
G.N. Richards, J. Kolbe, J. Fenwick, H.H. Rea.
Demographic characteristics of patients with severe life threatening asthma: comparison with asthma deaths.
Thorax, 48 (1993), pp. 1.105-1.109
[7.]
D.A. Campbell, G. McLennan, J.R. Coates, P.A. Frith, P.A. Gluyas, K.M. Latimer, et al.
A comparison of asthma deaths and near fatal asthma attacks in South Australia.
Eur Respir J, 7 (1994), pp. 490-497
[8.]
D.W. Hudgel, M. Capehart, J. Hirsch.
Ventilation response and drive during hypoxia in adult patients with asthma.
Chest, 76 (1979), pp. 294-299
[9.]
W.A. Whitelaw, J.P. Derenne, J. Milic-Emili.
Occlusion pressure as a measure of respiratory center output in conscious man.
Respir Physiol, 23 (1975), pp. 181-199
[10.]
M.J. Connolly, J.J. Crowley, N.B. Charan, C.P. Nelsen, R.E. Vestal.
Reduced subjective awareness of bronchoconstriction provoked by methacholine in elderly asthmatic and normal subjects as measured on a simple awareness scale.
Thorax, 47 (1992), pp. 410-413
[11.]
Y. Kikuchi, S. Okabe, G. Tamura, W. Hida, M. Homma, K. Shirato, T. Takishima.
Chemosensitivity and perception of dyspnea in patients with a history of near-fatal asthma.
N Engl J Med, 330 (1994), pp. 1.329-1.334
[12.]
E.R. McFadden Jr..
Fatal and near-fatal asthma.
N Engl J Med, 324 (1991), pp. 409-411
[13.]
J.D. Wilson, D.C. Sutherland, A.C. Thomas.
Has the change to betaagonists combined with oral theophylline increased cases of fatal asthma?.
Lancet, 1 (1981), pp. 1.235-1.237
[14.]
L.J. Nannini.
Mortalidad asociada al asma en el municipio de Rosario.
Medicina, 55 (1995), pp. 647-651
[15.]
W.H.M. Inman, A.M. Adelstein.
A rise and fall of asthma mortality in England and Wales in relation to use of pressurized aerosols.
Lancet, 2 (1969), pp. 279-283
[16.]
S.M. Brooks, S. Mintz, E. Weiss.
Changes occurring after freon inhalation.
Am Rev Respir Dis, 105 (1972), pp. 640-643
[17.]
E. McFadden Jr..
Regis. Inhaled aerosol bronchodilators.
Williams & Wilkins, (1986),
[18.]
W.O. Spitzer, S. Suissa, P. Ernst, R.I. Horwitz, B. Habbick, D. Cockcroft, et al.
The use of beta-agonists and the risk of death and near death from asthma.
N Engl J Med, 326 (1992), pp. 501-506
[19.]
J. Grainger, K. Woodman, N. Pearce, J. Crane, C. Burgess, A. Keane, et al.
Prescribed fenoterol and death from asthma in New Zealand, 1981-87: a further case-control study.
Thorax, 46 (1991), pp. 105-111
[20.]
M.R. Sears, D.R. Taylor, C.G. Print, D.C. Lake, L. Quingqing, E.M. Flannery, et al.
Regular inhaled beta-agonist treatment in bronchial asthma.
The Lancet, 336 (1990), pp. 1.391-1.396
[21.]
P.J. Barnes, K. Fan Chung.
Questions about inhaled beta, adrenoceptor agonists in asthma.
Trends in Pharmacol Sci, 13 (1992), pp. 20-23
[22.]
S. Sur, T.B. Crotty, G.M. Kephart, B.A. Hyma, T.V. Colby, C.E. Reed, et al.
Sudden onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa?.
Am Rev Respir Dis, 148 (1993), pp. 713-719
[23.]
Z.L. Wang, A.M. Bramley, A. McNamara, P.D. Paré, T.R. Bai.
Chronic fenoterol exposure increases in vivo and in vitro airway responses in guinea pigs.
Am J Respir Crit Care Med, 149 (1994), pp. 960-965
[24.]
T.E. Barret, B.L. Strom.
Inhaled beta-adrenergic receptor agonists in asthma: more harm than good?.
Am J Respir Crit Care Med, 151 (1995), pp. 574-577
[25.]
N.A. Molfino, L.J. Nannini Jr., K.R. Chapman, A.S. Slutsky.
Trends in pharmacotherapy for chronic airflow limitation in Argentina: 1983-1990.
Medicina, 54 (1994), pp. 103-109
[26.]
C.P. Criée, G.L. Groeneveld, C.H. Quast, R. Lüdtke, U. Hüttermann.
Use of beta-agonists and mortality in patients with stable COPD.
Chest, 102 (1993), pp. 114
[27.]
N.A. Martelli, L.J. Nannini, J.R. Moncalvo, G. Menga.
Lack of arrythmias in patients with acute severe asthma nebulized with salbutamol in air.
Am Rev Respir Dis, 135 (1987),
[28.]
N.A. Molfino, L.J. Nannini, A.N. Martelli, A.S. Slutsky.
Respiratory arrest in near fatal asthma.
New Engl J Med, 324 (1991), pp. 285-288
[29.]
D.W. Cockcroft, C.P. McParland, S.A. Brito, V.A. Swystun, B.C. Rutherford.
Regular inhaled salbutamol and airway responsiveness to allergen.
Lancet, 342 (1993), pp. 833-837
[30.]
B.J. O’Connor, S.L. Aikman, P.J. Bames.
Tolerance to the nonbron-chodilator effects of inhaled beta2, agonists in asthma.
New Engl J Med, 327 (1992), pp. 1.204-1.208
[31.]
J.P. Knochel.
Neuromuscular manifestations of electrolyte disorders.
Am J Med, 72 (1982), pp. 521-535
[32.]
A.J. Roncoroni, J.H.A. Adrogue, C.W. DeObrutsky, et al.
Metabolic acidosis in status asthmaticus.
Respiration, 33 (1976), pp. 85-94
[33.]
A.N. Martelli, C. Otero, B. Gil, S. González.
Fenoterol and serum potassium.
Lancet, 1 (1989), pp. 1.197
[34.]
J. Bodenhamer, R. Bergstrom, D. Brown, P. Gabow, J.A. Marx, S.R. Lowenstein.
Frequently nebulized β agonists for asthma: effects on serum electrolytes.
Ann Emerg Med, 21 (1992), pp. 1.337-1.342
[35.]
L.J. Nannini, N.A. Molfino.
Asma potencialmente fatal.
Mar del Plata: Actas del XXI Congreso Argentino de Tisiología y Neumonología, (1987),
[36.]
R. Bellomo, P. McLaughlin, E. Tai, G. Parkin.
Asthma requiring mechanical ventilation.
Chest, 105 (1994), pp. 891-896
[37.]
C.H. Marquette, F. Saulnier, O. Leroy, B. Wallaert, C. Chopin, J.M. Demarq, et al.
Long term prognosis of near-fatal asthma.
Am Rev Respir Dis, 146 (1992), pp. 76-81
[38.]
N.A. Molfino, L.J. Nannini, A. Rebuck, A.S. Slutsky.
The fatality prone asthmatic patients. Follow up study after near fatal attacks.
Chest, 101 (1992), pp. 621-623
[39.]
A. Ferrer, A. Torres, J. Roca, J. Sunyer, J.M. Antó, R. Rodríguez Roisín.
Characteristics of patients with soybean dust-induced acute severe asthma requiring mechanical ventilation.
Eur Respir J, 3 (1990), pp. 429-433
[40.]
J.M. Antó, J. Sunyer, R. Rodríguez Roisín, M. Suárez-Cervera, L. Vázquez.
Community outbreaks of asthma associated with inhalation of soybean dust.
N Engl J Med, 320 (1989), pp. 1.097-1.102
[41.]
M. Aceves, J.O. Grimalt, J. Sunyer, J.M. Antó, C.E. Reed.
Identification of soybean dust as an epidemic asthma agent in urban areas by molecular marker and RAST analysis of aerosols.
J Allergy Clin Immunol, 88 (1991), pp. 124-134
[42.]
C. Picado.
Barcelona's asthma epidemics: clinical aspects and intriguing findings.
Thorax, 47 (1992), pp. 197-200
[43.]
M.T. O’Hollaren, J.W. Yunginger, K.P. Offord, M.J. Somers, E.J. O’Connell, D.J. Ballard, et al.
Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma.
N Engl J Med, 324 (1991), pp. 359-363
[44.]
G.E. Packe, J.G. Ayres.
Asthma outbreak during a thunderstorm.
Lancet, 2 (1986), pp. 199-204
[45.]
I.K. Slepian, K.P. Mathews, J.A. McLean.
Aspirin-sensitive asthma.
Chest, 85 (1985), pp. 386-391
[46.]
N.A. Martelli.
Bronchial and intravenous provocation tests with indomethacin in aspirin-sensitive asthmatics.
Am Rev Respir Dis, 120 (1979), pp. 1.073-1.079
[47.]
J.T. Chiu.
Improvement in aspirin-sensitive asthmatic subjects after rapid aspirin desensitization and aspirin maintenance treatment.
J Allergy Clin Immunol, 71 (1983), pp. 50
[48.]
NHLBI.
Guidelines for the diagnosis and management of asthma.
J Allergy Clin Immunol, 88 (1991), pp. 2
[49.]
W. Wright, Y.G. Zhang, C.M. Salome, A.J. Woolcock.
Effect of inhaled preservatives on asthmatic subjects (I).
Sodium metabisulfite. Am Rev Respir Dis, 141 (1990), pp. 1.400-1.404
[50.]
G.M. Nichol, A. Nix, K.F. Chung, P.J. Bames.
Characterisation of bronchoconstrictor responses to sodium metabisulphite aerosol in atopic subjects with and without asthma.
Thorax, 44 (1989), pp. 1.009-1.014
[51.]
L.J. Nannini Jr., D. Hofer.
Effect of inhaled magnesium sulfate on sodium metabisulfite-induced bronchoconstriction in asthma.
Chest, 111 (1997),
[52.]
E. Mansour, A. Ahmed, A. Cortés, J. Caplan, R.M. Burch, W.M. Abraham.
Mechanisms of metabisulfite-induced bronchoconstriction: evidence for bradykinin B, receptor stimulation.
J Appl Physiol, 72 (1992), pp. 1.831-1.837
[53.]
P.I. Field, M. McClean, R. Simmul, N. Berend.
Comparison of sulphur dioxide and metabisulphite airway reactivity in subjects with asthma.
Thorax, 49 (1994), pp. 250-256
[54.]
R.S. McNeill.
Effect of beta-adrenergic-blocking agent, propranolol, on asthmatics.
Lancet, 2 (1964), pp. 1.101-1.102
[55.]
N. Songür, M. Fujimura, K. Mizuhashi, M. Saito, Q. Xiu, T. Matsuda.
Involvement of thromboxane A2 in propranolol-induced bronchoconstriction after allergic bronchoconstriction in guinea pigs.
Am J Respir Care Med, 149 (1994), pp. 1.488-1.493
[56.]
J.H. Toogood.
Beta-blocker therapy and the risk of anaphylaxis.
Can Med Assoc J, 136 (1987), pp. 929-933
[57.]
D.W. Empey, L.A. Laitinen, L. Jacobs, W.M. Gold, J.A. Nadel.
Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection.
Am Rev Respir Dis, 113 (1976), pp. 131-139
[58.]
D. Cheung, E.C. Dick, M.C. Timmers, E.P.A. De Klerk, W.J.M. Spaan, P.J. Sterk.
Rhinovirus inhalation causes long-lasting excessive airway narrowing in response to methacholine in asthmatic subjects in vivo.
Am J Respir Crit Care Med, 152 (1995), pp. 1.490-1.496
[59.]
W.W. Busse, J.K. Kiecolt-Glaser, C. Coe, R.J. Martin, S.T. Weiss, S.R. Parker.
Stress and asthma.
Am J Respir Crit Care Med, 151 (1995), pp. 249-252
[60.]
P.A. Corris, J.H. Dark.
Aetiology of asthma: lessons from lung transplantation.
Lancet, 341 (1993), pp. 1.369-1.371
[61.]
H.H. Rea, R. Scragg, R. Jackson, R. Beaglehole, J. Fenwick, D.C. Sutherland.
A case-control study of death from asthma.
Thorax, 41 (1986), pp. 833-839
[62.]
M.R. Hetzell, T.J.H. Clark, M.A. Branthwaite.
Asthma: analysis of sudden deaths and ventilatory arrests in hospital.
Br Med J, 1 (1977), pp. 1.808-1.811
[63.]
British Thoracic Association.
Death from asthma in two regions of England.
Br Med J, 285 (1982), pp. 1.251-1.255
[64.]
S. Benatar.
Fatal asthma.
New Engl J Med, 314 (1986), pp. 423-429
[68.]
R. Darioli, C. Perret.
Mechanical controlled hypoventilation in status asthmaticus.
Am Rev Respir Dis, 129 (1984), pp. 385-387
[69.]
S. Salmeron, L. Brochard, H. Mal, A. Tenaillon, M. Henry-amar, D. Renon, et al.
Nebulized versus intravenous albuterol in hypercapnic acute asthma.
Am J Respir Crit Care Med, 149 (1994), pp. 1.466-1.470
[70.]
T.C. Corbridge, J.B. Hall.
The assessment and management of adults with status asthmaticus.
Am J Respir Crit Care Med, 151 (1995), pp. 1.296-1.316
[71.]
D.V. Tuxen, T.J. Williams, C.D. Scheinkestel, D. Czamy, G. Bowes.
Use of a measurement of pulmonary hyperinflation to control the level of mechanical ventilation in patients with acute severe asthma.
Am Rev Respir Dis, 146 (1992), pp. 1.136-1.142
[72.]
F. Feihl, C. Perret.
Permissive hypercapnia. How permissive should we be?.
Am J Respir Crit Care Med, 150 (1994), pp. 1.722-1.737
[73.]
S.M. Menitove, R.M. Godring.
Combined ventilator and bicarbonate strategy in the management of status asthmaticus.
Am J Med, 74 (1983), pp. 898-901
[74.]
A.C. Raimondi, G. Olmedo, A.J. Roncoroni.
Terapia intensiva en el mal asmático.
Rev Clin Española, 118 (1970), pp. 547-558
[75.]
A.S. Slutsky.
Consensus conference.
Mechanical ventilation Chest, 104 (1993), pp. 1.833-1.859
[76.]
P.J. Bames.
Inhaled glucocorticoids for asthma.
New Engl J Med, 332 (1995), pp. 868-875
[78.]
R.M. McNamara, W.H. Spivey, E. Skobeloff, S. Jacubowitz.
Intravenous magnesium sulfate in the management of acute respiratory failure complicating asthma.
Ann Emerg Med, 18 (1989), pp. 197-199
[79.]
L.M. Kuitert, S.L. Kletchko.
Intravenous magnesium sulfate in acute, life threatening asthma.
Ann Emerg Med, 20 (1991), pp. 1.2431.245
[80.]
M. Sydow, T.A. Crozier, S. Zielmann, J. Radke, H. Burchardi.
High dose intravenous magnesium sulfate in the management of life threatening status asthmaticus.
Intensive Care Med, 19 (1993), pp. 467-471
[81.]
H. Okayama, M. Okayama, Aikawa t, H. Sasaki, T. Takishima.
Treatment of status asthmaticus with intravenous magnesium sulfate.
J Asthma, 28 (1991), pp. 11-17
[82.]
G.U. Meduri, N. Abou-Shala, R.C. Fox, C.B. Jones, K.V. Leeper, R.G. Wunderink.
Noninvasive face mask mechanical ventilation in patients with acute hypercapnic respiratory failure.
Chest, 100 (1991), pp. 445-454
[83.]
M. Echeverría, A.W. Gelb, H.R. Wexler, D. Ahmad, P. Kenefick.
Enflurane and halothane in status asthmaticus.
Chest, 89 (1986), pp. 153-154
[84.]
J.E. Kass, R.J. Castriotta.
Heliox therapy in acute severe asthma.
Chest, 107 (1995), pp. 757-760
[85.]
M.B. Shapiro, A.C. Kleaveland, R.H. Bartlett.
Extracorporeal lite support for status asthmaticus.
Chest, 103 (1993), pp. 1.651-1.654
[86.]
D.J. Cooper, D.V. Tuxen, M.M. Fisher.
Extracorporeal life support for status asthmaticus.
Chest, 106 (1994), pp. 978
[87.]
D.A. Campbell, G. McLennan, J.R. Coates, P.A. Frith, P.A. Gluyas, K.M. Latimer, et al.
Near fatal asthma attacks: the reliability of descriptive information collected from close acquaintances.
Thorax, 48 (1993), pp. 1.099-1.104
[88.]
L.P. Boulet, F. Deschesnes, H. Turcotte, F. Gignac.
Near-fatal asthma: clinical and physiologic features, perception of bronchoconstriction, and psychologic profile.
J Allergy Clin Immunol, 88 (1991), pp. 838-846
[89.]
B. Higgins, A.P. Greening, G.K. Crompton.
Assisted ventilation in severe acute asthma.
Thorax, 41 (1986), pp. 464-467
[90.]
A.R. Luksza, P. Smith, J. Coakley, I.J. Gordan, S.T. Atherton.
Acute severe asthma treated by mechanical ventilation: 10 years’ experience from a district general hospital.
Thorax, 41 (1986), pp. 459-463
[91.]
T.P. Miller, P.A. Greenberger, R. Patterson.
The diagnosis of potentially fatal asthma in hospitalized adults.
Chest, 102 (1992), pp. 515-518
[92.]
R.E. Ruffin, K.M. Latimer, D. Schembri.
Longitudinal study of near fatal asthma.
Am Rev Respir Dis, 139 (1989), pp. 68
[93.]
C.H. Scoggin, S.A. Sahn, T.L. Petty.
Status asthmaticus. A nine-year experience.
JAMA, 238 (1977), pp. 1.158-1.162
[94.]
A.F. Sheehy, R. DiBenedetto, S. Lefrak, H.A. Lyons.
Treatment of status asthmaticus.
Arch Intem Med, 130 (1972), pp. 37-42
[95.]
J.B. Wasserfallen, M.D. Schaller, F. Feihl, C.H. Perret.
Sudden asphyxic asthma: a distinct entity?.
Am Rev Respir Dis, 142 (1990), pp. 108-111
[96.]
D.E. Westerman, S.R. Benatar, P.D. Potgieter, A.D. Ferguson.
Identification of the high-risk asthmatic patient.
Am J Med, 66 (1979), pp. 565-572
[97.]
J.L. Zimmerman, P.R. Dellinger, A.N. Shah, R.W. Taylor.
Endotracheal intubation and mechanical ventilation in severe asthma.
Crit Care Med, 21 (1993), pp. 1.727-1.730
[98.]
J.W. Leatherman, W.L. Fluegel, W.S. David, S.F. Davies, C. Iber.
Muscle weakness in mechanically ventilated patients with severe asthma.
Am J Respir Crit Care Med, 153 (1996), pp. 1.686-1.690
Copyright © 1997. Sociedad Española de Neumología y Cirugía Torácica
